Medical Care
Global Brain Cancer Treatment Market Research Report 2025
- Apr 07, 25
- ID: 167567
- Pages: 76
- Figures: 77
- Views: 34
The global market for Brain Cancer Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Brain Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Cancer Treatment.
The Brain Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Brain Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
F. Hoffmann-La Roche Ltd
Pfizer,Inc
Y-mAbs Therapeutics,Inc
Merck & Co.Inc
Johnson & Johnson
AstraZeneca
Bristol-Myers Squibb
Amgen Inc
GlaxoSmith Kline PLC
Segment by Type
Chemotherapy
Immunotherapy
Targeted Therapy
Others
Segment by Application
Primary Brain Cancer
Secondary Brain Cancer
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Cancer Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Brain Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Cancer Treatment.
The Brain Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Brain Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
F. Hoffmann-La Roche Ltd
Pfizer,Inc
Y-mAbs Therapeutics,Inc
Merck & Co.Inc
Johnson & Johnson
AstraZeneca
Bristol-Myers Squibb
Amgen Inc
GlaxoSmith Kline PLC
Segment by Type
Chemotherapy
Immunotherapy
Targeted Therapy
Others
Segment by Application
Primary Brain Cancer
Secondary Brain Cancer
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Cancer Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Brain Cancer Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Primary Brain Cancer
1.3.3 Secondary Brain Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Cancer Treatment Market Perspective (2020-2031)
2.2 Global Brain Cancer Treatment Growth Trends by Region
2.2.1 Global Brain Cancer Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Brain Cancer Treatment Historic Market Size by Region (2020-2025)
2.2.3 Brain Cancer Treatment Forecasted Market Size by Region (2026-2031)
2.3 Brain Cancer Treatment Market Dynamics
2.3.1 Brain Cancer Treatment Industry Trends
2.3.2 Brain Cancer Treatment Market Drivers
2.3.3 Brain Cancer Treatment Market Challenges
2.3.4 Brain Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Cancer Treatment Players by Revenue
3.1.1 Global Top Brain Cancer Treatment Players by Revenue (2020-2025)
3.1.2 Global Brain Cancer Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Brain Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Brain Cancer Treatment Revenue
3.4 Global Brain Cancer Treatment Market Concentration Ratio
3.4.1 Global Brain Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Cancer Treatment Revenue in 2024
3.5 Global Key Players of Brain Cancer Treatment Head office and Area Served
3.6 Global Key Players of Brain Cancer Treatment, Product and Application
3.7 Global Key Players of Brain Cancer Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Cancer Treatment Breakdown Data by Type
4.1 Global Brain Cancer Treatment Historic Market Size by Type (2020-2025)
4.2 Global Brain Cancer Treatment Forecasted Market Size by Type (2026-2031)
5 Brain Cancer Treatment Breakdown Data by Application
5.1 Global Brain Cancer Treatment Historic Market Size by Application (2020-2025)
5.2 Global Brain Cancer Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Brain Cancer Treatment Market Size (2020-2031)
6.2 North America Brain Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Brain Cancer Treatment Market Size by Country (2020-2025)
6.4 North America Brain Cancer Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Cancer Treatment Market Size (2020-2031)
7.2 Europe Brain Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Brain Cancer Treatment Market Size by Country (2020-2025)
7.4 Europe Brain Cancer Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Cancer Treatment Market Size (2020-2031)
8.2 Asia-Pacific Brain Cancer Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Brain Cancer Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Brain Cancer Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Cancer Treatment Market Size (2020-2031)
9.2 Latin America Brain Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Brain Cancer Treatment Market Size by Country (2020-2025)
9.4 Latin America Brain Cancer Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Cancer Treatment Market Size (2020-2031)
10.2 Middle East & Africa Brain Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Brain Cancer Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Brain Cancer Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Brain Cancer Treatment Introduction
11.1.4 Novartis AG Revenue in Brain Cancer Treatment Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Brain Cancer Treatment Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Brain Cancer Treatment Business (2020-2025)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Pfizer,Inc
11.3.1 Pfizer,Inc Company Details
11.3.2 Pfizer,Inc Business Overview
11.3.3 Pfizer,Inc Brain Cancer Treatment Introduction
11.3.4 Pfizer,Inc Revenue in Brain Cancer Treatment Business (2020-2025)
11.3.5 Pfizer,Inc Recent Development
11.4 Y-mAbs Therapeutics,Inc
11.4.1 Y-mAbs Therapeutics,Inc Company Details
11.4.2 Y-mAbs Therapeutics,Inc Business Overview
11.4.3 Y-mAbs Therapeutics,Inc Brain Cancer Treatment Introduction
11.4.4 Y-mAbs Therapeutics,Inc Revenue in Brain Cancer Treatment Business (2020-2025)
11.4.5 Y-mAbs Therapeutics,Inc Recent Development
11.5 Merck & Co.Inc
11.5.1 Merck & Co.Inc Company Details
11.5.2 Merck & Co.Inc Business Overview
11.5.3 Merck & Co.Inc Brain Cancer Treatment Introduction
11.5.4 Merck & Co.Inc Revenue in Brain Cancer Treatment Business (2020-2025)
11.5.5 Merck & Co.Inc Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Brain Cancer Treatment Introduction
11.6.4 Johnson & Johnson Revenue in Brain Cancer Treatment Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Brain Cancer Treatment Introduction
11.7.4 AstraZeneca Revenue in Brain Cancer Treatment Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Brain Cancer Treatment Introduction
11.8.4 Bristol-Myers Squibb Revenue in Brain Cancer Treatment Business (2020-2025)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Amgen Inc
11.9.1 Amgen Inc Company Details
11.9.2 Amgen Inc Business Overview
11.9.3 Amgen Inc Brain Cancer Treatment Introduction
11.9.4 Amgen Inc Revenue in Brain Cancer Treatment Business (2020-2025)
11.9.5 Amgen Inc Recent Development
11.10 GlaxoSmith Kline PLC
11.10.1 GlaxoSmith Kline PLC Company Details
11.10.2 GlaxoSmith Kline PLC Business Overview
11.10.3 GlaxoSmith Kline PLC Brain Cancer Treatment Introduction
11.10.4 GlaxoSmith Kline PLC Revenue in Brain Cancer Treatment Business (2020-2025)
11.10.5 GlaxoSmith Kline PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Brain Cancer Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Primary Brain Cancer
1.3.3 Secondary Brain Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Cancer Treatment Market Perspective (2020-2031)
2.2 Global Brain Cancer Treatment Growth Trends by Region
2.2.1 Global Brain Cancer Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Brain Cancer Treatment Historic Market Size by Region (2020-2025)
2.2.3 Brain Cancer Treatment Forecasted Market Size by Region (2026-2031)
2.3 Brain Cancer Treatment Market Dynamics
2.3.1 Brain Cancer Treatment Industry Trends
2.3.2 Brain Cancer Treatment Market Drivers
2.3.3 Brain Cancer Treatment Market Challenges
2.3.4 Brain Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Cancer Treatment Players by Revenue
3.1.1 Global Top Brain Cancer Treatment Players by Revenue (2020-2025)
3.1.2 Global Brain Cancer Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Brain Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Brain Cancer Treatment Revenue
3.4 Global Brain Cancer Treatment Market Concentration Ratio
3.4.1 Global Brain Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Cancer Treatment Revenue in 2024
3.5 Global Key Players of Brain Cancer Treatment Head office and Area Served
3.6 Global Key Players of Brain Cancer Treatment, Product and Application
3.7 Global Key Players of Brain Cancer Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Cancer Treatment Breakdown Data by Type
4.1 Global Brain Cancer Treatment Historic Market Size by Type (2020-2025)
4.2 Global Brain Cancer Treatment Forecasted Market Size by Type (2026-2031)
5 Brain Cancer Treatment Breakdown Data by Application
5.1 Global Brain Cancer Treatment Historic Market Size by Application (2020-2025)
5.2 Global Brain Cancer Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Brain Cancer Treatment Market Size (2020-2031)
6.2 North America Brain Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Brain Cancer Treatment Market Size by Country (2020-2025)
6.4 North America Brain Cancer Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Cancer Treatment Market Size (2020-2031)
7.2 Europe Brain Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Brain Cancer Treatment Market Size by Country (2020-2025)
7.4 Europe Brain Cancer Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Cancer Treatment Market Size (2020-2031)
8.2 Asia-Pacific Brain Cancer Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Brain Cancer Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Brain Cancer Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Cancer Treatment Market Size (2020-2031)
9.2 Latin America Brain Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Brain Cancer Treatment Market Size by Country (2020-2025)
9.4 Latin America Brain Cancer Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Cancer Treatment Market Size (2020-2031)
10.2 Middle East & Africa Brain Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Brain Cancer Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Brain Cancer Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Brain Cancer Treatment Introduction
11.1.4 Novartis AG Revenue in Brain Cancer Treatment Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Brain Cancer Treatment Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Brain Cancer Treatment Business (2020-2025)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Pfizer,Inc
11.3.1 Pfizer,Inc Company Details
11.3.2 Pfizer,Inc Business Overview
11.3.3 Pfizer,Inc Brain Cancer Treatment Introduction
11.3.4 Pfizer,Inc Revenue in Brain Cancer Treatment Business (2020-2025)
11.3.5 Pfizer,Inc Recent Development
11.4 Y-mAbs Therapeutics,Inc
11.4.1 Y-mAbs Therapeutics,Inc Company Details
11.4.2 Y-mAbs Therapeutics,Inc Business Overview
11.4.3 Y-mAbs Therapeutics,Inc Brain Cancer Treatment Introduction
11.4.4 Y-mAbs Therapeutics,Inc Revenue in Brain Cancer Treatment Business (2020-2025)
11.4.5 Y-mAbs Therapeutics,Inc Recent Development
11.5 Merck & Co.Inc
11.5.1 Merck & Co.Inc Company Details
11.5.2 Merck & Co.Inc Business Overview
11.5.3 Merck & Co.Inc Brain Cancer Treatment Introduction
11.5.4 Merck & Co.Inc Revenue in Brain Cancer Treatment Business (2020-2025)
11.5.5 Merck & Co.Inc Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Brain Cancer Treatment Introduction
11.6.4 Johnson & Johnson Revenue in Brain Cancer Treatment Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Brain Cancer Treatment Introduction
11.7.4 AstraZeneca Revenue in Brain Cancer Treatment Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Brain Cancer Treatment Introduction
11.8.4 Bristol-Myers Squibb Revenue in Brain Cancer Treatment Business (2020-2025)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Amgen Inc
11.9.1 Amgen Inc Company Details
11.9.2 Amgen Inc Business Overview
11.9.3 Amgen Inc Brain Cancer Treatment Introduction
11.9.4 Amgen Inc Revenue in Brain Cancer Treatment Business (2020-2025)
11.9.5 Amgen Inc Recent Development
11.10 GlaxoSmith Kline PLC
11.10.1 GlaxoSmith Kline PLC Company Details
11.10.2 GlaxoSmith Kline PLC Business Overview
11.10.3 GlaxoSmith Kline PLC Brain Cancer Treatment Introduction
11.10.4 GlaxoSmith Kline PLC Revenue in Brain Cancer Treatment Business (2020-2025)
11.10.5 GlaxoSmith Kline PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Brain Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Others
Table 6. Global Brain Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Brain Cancer Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Brain Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Brain Cancer Treatment Market Share by Region (2020-2025)
Table 10. Global Brain Cancer Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Brain Cancer Treatment Market Share by Region (2026-2031)
Table 12. Brain Cancer Treatment Market Trends
Table 13. Brain Cancer Treatment Market Drivers
Table 14. Brain Cancer Treatment Market Challenges
Table 15. Brain Cancer Treatment Market Restraints
Table 16. Global Brain Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Brain Cancer Treatment Market Share by Players (2020-2025)
Table 18. Global Top Brain Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Treatment as of 2024)
Table 19. Ranking of Global Top Brain Cancer Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Brain Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Brain Cancer Treatment, Headquarters and Area Served
Table 22. Global Key Players of Brain Cancer Treatment, Product and Application
Table 23. Global Key Players of Brain Cancer Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Brain Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Brain Cancer Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Brain Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Brain Cancer Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Brain Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Brain Cancer Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Brain Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Brain Cancer Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Brain Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Brain Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Brain Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Brain Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Brain Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Brain Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Brain Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Brain Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Brain Cancer Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Brain Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Brain Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Brain Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Brain Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Brain Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Brain Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Novartis AG Company Details
Table 49. Novartis AG Business Overview
Table 50. Novartis AG Brain Cancer Treatment Product
Table 51. Novartis AG Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 52. Novartis AG Recent Development
Table 53. F. Hoffmann-La Roche Ltd Company Details
Table 54. F. Hoffmann-La Roche Ltd Business Overview
Table 55. F. Hoffmann-La Roche Ltd Brain Cancer Treatment Product
Table 56. F. Hoffmann-La Roche Ltd Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 57. F. Hoffmann-La Roche Ltd Recent Development
Table 58. Pfizer,Inc Company Details
Table 59. Pfizer,Inc Business Overview
Table 60. Pfizer,Inc Brain Cancer Treatment Product
Table 61. Pfizer,Inc Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 62. Pfizer,Inc Recent Development
Table 63. Y-mAbs Therapeutics,Inc Company Details
Table 64. Y-mAbs Therapeutics,Inc Business Overview
Table 65. Y-mAbs Therapeutics,Inc Brain Cancer Treatment Product
Table 66. Y-mAbs Therapeutics,Inc Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 67. Y-mAbs Therapeutics,Inc Recent Development
Table 68. Merck & Co.Inc Company Details
Table 69. Merck & Co.Inc Business Overview
Table 70. Merck & Co.Inc Brain Cancer Treatment Product
Table 71. Merck & Co.Inc Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 72. Merck & Co.Inc Recent Development
Table 73. Johnson & Johnson Company Details
Table 74. Johnson & Johnson Business Overview
Table 75. Johnson & Johnson Brain Cancer Treatment Product
Table 76. Johnson & Johnson Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 77. Johnson & Johnson Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Brain Cancer Treatment Product
Table 81. AstraZeneca Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Bristol-Myers Squibb Company Details
Table 84. Bristol-Myers Squibb Business Overview
Table 85. Bristol-Myers Squibb Brain Cancer Treatment Product
Table 86. Bristol-Myers Squibb Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 87. Bristol-Myers Squibb Recent Development
Table 88. Amgen Inc Company Details
Table 89. Amgen Inc Business Overview
Table 90. Amgen Inc Brain Cancer Treatment Product
Table 91. Amgen Inc Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 92. Amgen Inc Recent Development
Table 93. GlaxoSmith Kline PLC Company Details
Table 94. GlaxoSmith Kline PLC Business Overview
Table 95. GlaxoSmith Kline PLC Brain Cancer Treatment Product
Table 96. GlaxoSmith Kline PLC Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 97. GlaxoSmith Kline PLC Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Brain Cancer Treatment Picture
Figure 2. Global Brain Cancer Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Brain Cancer Treatment Market Share by Type: 2024 VS 2031
Figure 4. Chemotherapy Features
Figure 5. Immunotherapy Features
Figure 6. Targeted Therapy Features
Figure 7. Others Features
Figure 8. Global Brain Cancer Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Brain Cancer Treatment Market Share by Application: 2024 VS 2031
Figure 10. Primary Brain Cancer Case Studies
Figure 11. Secondary Brain Cancer Case Studies
Figure 12. Brain Cancer Treatment Report Years Considered
Figure 13. Global Brain Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Brain Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Brain Cancer Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Brain Cancer Treatment Market Share by Players in 2024
Figure 17. Global Top Brain Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Brain Cancer Treatment Revenue in 2024
Figure 19. North America Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Brain Cancer Treatment Market Share by Country (2020-2031)
Figure 21. United States Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Brain Cancer Treatment Market Share by Country (2020-2031)
Figure 25. Germany Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Brain Cancer Treatment Market Share by Region (2020-2031)
Figure 33. China Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Brain Cancer Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Brain Cancer Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis AG Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 49. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 50. Pfizer,Inc Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 51. Y-mAbs Therapeutics,Inc Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 52. Merck & Co.Inc Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 53. Johnson & Johnson Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 54. AstraZeneca Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 56. Amgen Inc Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 57. GlaxoSmith Kline PLC Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Brain Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Others
Table 6. Global Brain Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Brain Cancer Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Brain Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Brain Cancer Treatment Market Share by Region (2020-2025)
Table 10. Global Brain Cancer Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Brain Cancer Treatment Market Share by Region (2026-2031)
Table 12. Brain Cancer Treatment Market Trends
Table 13. Brain Cancer Treatment Market Drivers
Table 14. Brain Cancer Treatment Market Challenges
Table 15. Brain Cancer Treatment Market Restraints
Table 16. Global Brain Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Brain Cancer Treatment Market Share by Players (2020-2025)
Table 18. Global Top Brain Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Treatment as of 2024)
Table 19. Ranking of Global Top Brain Cancer Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Brain Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Brain Cancer Treatment, Headquarters and Area Served
Table 22. Global Key Players of Brain Cancer Treatment, Product and Application
Table 23. Global Key Players of Brain Cancer Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Brain Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Brain Cancer Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Brain Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Brain Cancer Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Brain Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Brain Cancer Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Brain Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Brain Cancer Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Brain Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Brain Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Brain Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Brain Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Brain Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Brain Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Brain Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Brain Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Brain Cancer Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Brain Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Brain Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Brain Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Brain Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Brain Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Brain Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Novartis AG Company Details
Table 49. Novartis AG Business Overview
Table 50. Novartis AG Brain Cancer Treatment Product
Table 51. Novartis AG Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 52. Novartis AG Recent Development
Table 53. F. Hoffmann-La Roche Ltd Company Details
Table 54. F. Hoffmann-La Roche Ltd Business Overview
Table 55. F. Hoffmann-La Roche Ltd Brain Cancer Treatment Product
Table 56. F. Hoffmann-La Roche Ltd Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 57. F. Hoffmann-La Roche Ltd Recent Development
Table 58. Pfizer,Inc Company Details
Table 59. Pfizer,Inc Business Overview
Table 60. Pfizer,Inc Brain Cancer Treatment Product
Table 61. Pfizer,Inc Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 62. Pfizer,Inc Recent Development
Table 63. Y-mAbs Therapeutics,Inc Company Details
Table 64. Y-mAbs Therapeutics,Inc Business Overview
Table 65. Y-mAbs Therapeutics,Inc Brain Cancer Treatment Product
Table 66. Y-mAbs Therapeutics,Inc Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 67. Y-mAbs Therapeutics,Inc Recent Development
Table 68. Merck & Co.Inc Company Details
Table 69. Merck & Co.Inc Business Overview
Table 70. Merck & Co.Inc Brain Cancer Treatment Product
Table 71. Merck & Co.Inc Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 72. Merck & Co.Inc Recent Development
Table 73. Johnson & Johnson Company Details
Table 74. Johnson & Johnson Business Overview
Table 75. Johnson & Johnson Brain Cancer Treatment Product
Table 76. Johnson & Johnson Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 77. Johnson & Johnson Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Brain Cancer Treatment Product
Table 81. AstraZeneca Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Bristol-Myers Squibb Company Details
Table 84. Bristol-Myers Squibb Business Overview
Table 85. Bristol-Myers Squibb Brain Cancer Treatment Product
Table 86. Bristol-Myers Squibb Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 87. Bristol-Myers Squibb Recent Development
Table 88. Amgen Inc Company Details
Table 89. Amgen Inc Business Overview
Table 90. Amgen Inc Brain Cancer Treatment Product
Table 91. Amgen Inc Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 92. Amgen Inc Recent Development
Table 93. GlaxoSmith Kline PLC Company Details
Table 94. GlaxoSmith Kline PLC Business Overview
Table 95. GlaxoSmith Kline PLC Brain Cancer Treatment Product
Table 96. GlaxoSmith Kline PLC Revenue in Brain Cancer Treatment Business (2020-2025) & (US$ Million)
Table 97. GlaxoSmith Kline PLC Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Brain Cancer Treatment Picture
Figure 2. Global Brain Cancer Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Brain Cancer Treatment Market Share by Type: 2024 VS 2031
Figure 4. Chemotherapy Features
Figure 5. Immunotherapy Features
Figure 6. Targeted Therapy Features
Figure 7. Others Features
Figure 8. Global Brain Cancer Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Brain Cancer Treatment Market Share by Application: 2024 VS 2031
Figure 10. Primary Brain Cancer Case Studies
Figure 11. Secondary Brain Cancer Case Studies
Figure 12. Brain Cancer Treatment Report Years Considered
Figure 13. Global Brain Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Brain Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Brain Cancer Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Brain Cancer Treatment Market Share by Players in 2024
Figure 17. Global Top Brain Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Brain Cancer Treatment Revenue in 2024
Figure 19. North America Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Brain Cancer Treatment Market Share by Country (2020-2031)
Figure 21. United States Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Brain Cancer Treatment Market Share by Country (2020-2031)
Figure 25. Germany Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Brain Cancer Treatment Market Share by Region (2020-2031)
Figure 33. China Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Brain Cancer Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Brain Cancer Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Brain Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis AG Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 49. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 50. Pfizer,Inc Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 51. Y-mAbs Therapeutics,Inc Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 52. Merck & Co.Inc Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 53. Johnson & Johnson Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 54. AstraZeneca Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 56. Amgen Inc Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 57. GlaxoSmith Kline PLC Revenue Growth Rate in Brain Cancer Treatment Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232